Gut Microbiota Features Associated With Campylobacter Burden and Postnatal Linear Growth Deficits in a Peruvian Birth

Saba Rouhani1, Nicholas W Griffin2,3, Pablo Peñataro Yori1,4

  • 1Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Insights

Campylobacter infection is common in Peruvian children and linked to impaired growth, even without symptoms. This study reveals how gut bacteria changes may explain these growth effects in early life.

Area of Science:

  • Pediatric infectious diseases
  • Microbiome research
  • Global child health

Background:

  • Campylobacter infection is prevalent in children in the Amazonian lowlands of Peru.
  • The infection is associated with impaired linear growth, even in asymptomatic cases.
  • Understanding the mechanisms linking infection, gut microbiota, and growth is crucial.

Purpose of the Study:

  • To investigate the association between Campylobacter infection, linear growth, and fecal microbial community composition.
  • To explore the role of gut microbiota disruptions in early-life growth impairment caused by asymptomatic infections.

Main Methods:

  • Prospective birth cohort study of 271 children.
  • Campylobacter detection via enzyme-linked immunosorbent assay.
  • 16S rRNA gene sequencing for fecal microbial analysis at multiple time points.
  • Multiple linear regression to assess associations with growth and microbial data.

Main Results:

  • Campylobacter was present in 93% of children's asymptomatic fecal samples.
  • Increased Campylobacter infection proportion correlated with reduced length-for-age z scores (LAZ).
  • Specific bacterial taxa were identified as indicators of Campylobacter burden and associated with other enteric pathogens.

Conclusions:

  • Campylobacter infection is frequent in this high-burden setting and alters gut microbial composition.
  • Fecal microbiota disruptions likely contribute to the negative impact of asymptomatic Campylobacter infections on child growth.
  • Findings highlight the importance of the gut microbiome in early-life development and disease.
Abstract